Vertex Cystic Fibrosis Combo Aids Breathing in Patients – BusinessWeek


Xconomy
Vertex Cystic Fibrosis Combo Aids Breathing in Patients
BusinessWeek
By Meg Tirrell on May 07, 2012 Vertex Pharmaceuticals Inc. (VRTX) (VRTX), maker of the first medicine to target the underlying cause of cystic fibrosis, said a combination of the drug and a second therapy improved some patients' ability to breathe in a
A One-Two Punch Against Cystic Fibrosis, And Maybe Someday Other Diseases TooForbes
Vertex reports interim analysis data from Phase 2 study of VX-809 and KalydecoRTT News
Vertex: Two-Drug Cystic Fibrosis Therapy Improves Lung FunctionTheStreet.com
Xconomy -Reuters AlertNet -PharmaLive (press release) (subscription)
all 3 news articles »
This entry was posted in Health and tagged . Bookmark the permalink.

Comments are closed.